×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TNDM – tandem diabetes care, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TNDM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/28
08:13 pm
tndm
Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Medium
Report
Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
3/26
10:16 am
tndm
3 Reasons to Sell TNDM and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons to Sell TNDM and 1 Stock to Buy Instead [Yahoo! Finance]
3/19
08:07 pm
tndm
TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology [Yahoo! Finance]
Low
Report
TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology [Yahoo! Finance]
3/19
10:00 am
tndm
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
Medium
Report
Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes
3/18
04:05 pm
tndm
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
Low
Report
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
3/18
09:50 am
tndm
3 Healthcare Stocks Walking a Fine Line [Yahoo! Finance]
Low
Report
3 Healthcare Stocks Walking a Fine Line [Yahoo! Finance]
3/5
08:08 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $22.00 price target on the stock, down previously from $45.00.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $22.00 price target on the stock, down previously from $45.00.
3/4
08:01 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $24.00 price target on the stock, down previously from $35.00.
Medium
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $24.00 price target on the stock, down previously from $35.00.
Date
Time
Symbol
Company Name
Action
%Chg
2/26/2025
04:05 pm
tndm
tandem diabetes care, inc.
BEAT
Report
-37.4%
tandem diabetes care, inc.
2/26/2025
04:05 pm
tndm
tandem diabetes care, inc.
BEAT
Report
-37.4%
tandem diabetes care, inc.
2/26/2025
04:05 pm
tndm
tandem diabetes care, inc.
BEAT
Report
-37.4%
tandem diabetes care, inc.
2/26/2025
04:05 pm
tndm
tandem diabetes care, inc.
BEAT
Report
-37.4%
tandem diabetes care, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
04:13 pm
tndm
Form 4 TANDEM DIABETES CARE For: Mar 17 Filed by: Novara Mark David
Low
Report
Form 4 TANDEM DIABETES CARE For: Mar 17 Filed by: Novara Mark David
3/19
04:12 pm
tndm
Form 4 TANDEM DIABETES CARE For: Mar 17 Filed by: Carpenter Rick
Low
Report
Form 4 TANDEM DIABETES CARE For: Mar 17 Filed by: Carpenter Rick
3/11
06:06 pm
tndm
Form 4 TANDEM DIABETES CARE For: Mar 07 Filed by: Kyrillos Jean-Claude
Low
Report
Form 4 TANDEM DIABETES CARE For: Mar 07 Filed by: Kyrillos Jean-Claude
2/27
05:16 pm
tndm
Form 4 TANDEM DIABETES CARE For: Feb 25 Filed by: Morrison Susan
Low
Report
Form 4 TANDEM DIABETES CARE For: Feb 25 Filed by: Morrison Susan
2/27
05:16 pm
tndm
Form 4 TANDEM DIABETES CARE For: Feb 25 Filed by: Vosseller Leigh
Low
Report
Form 4 TANDEM DIABETES CARE For: Feb 25 Filed by: Vosseller Leigh
2/27
05:15 pm
tndm
Form 4 TANDEM DIABETES CARE For: Feb 25 Filed by: Sheridan John F
Low
Report
Form 4 TANDEM DIABETES CARE For: Feb 25 Filed by: Sheridan John F
2/27
05:15 pm
tndm
Form 4 TANDEM DIABETES CARE For: Feb 25 Filed by: Gasser Elizabeth Anne
Low
Report
Form 4 TANDEM DIABETES CARE For: Feb 25 Filed by: Gasser Elizabeth Anne
2/26
04:10 pm
tndm
Form 10-K TANDEM DIABETES CARE For: Dec 31
High
Report
Form 10-K TANDEM DIABETES CARE For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/27
Tandem Diabetes Care Inc (NASDAQ: TNDM) had its price target lowered by analysts at Citigroup Inc from $89.00 to $74.00. They now have a "neutral" rating on the stock.
10.3%
10/14 Tandem Diabetes Care to Announce Third Quarter 2019 Financial Results on November 4, 2019 9.5%
11/4 Form 10-Q TANDEM DIABETES CARE For: Sep 30 7.6%
4/1 Keller Grover LLP Investigating Tandem Diabetes Care 7.0%
8/1 Q2/2019 6/30/2019 EPS -0.030 ZacksConsensus -0.230 ActVsEst 0.200 - Beat 7.0%
5/13 Tandem Diabetes Care Announces Upcoming Conference Presentations 6.8%
2/10 Form SC 13G/A TANDEM DIABETES CARE Filed by: WELLINGTON MANAGEMENT GROUP LLP 6.8%
4/29 Tandem Diabetes Care Q1 2020 Earnings Preview [Seeking Alpha] 5.8%
11/18 Form 4 TANDEM DIABETES CARE For: Nov 18 Filed by: Vosseller Leigh 5.8%
3/2 Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller 5.7%
10/14 Tandem Diabetes Care to Announce Third Quarter 2019 Financial Results on November 4, 2019 9.5%
11/4 Form 10-Q TANDEM DIABETES CARE For: Sep 30 7.6%
4/1 Keller Grover LLP Investigating Tandem Diabetes Care 7.0%
8/1 Q2/2019 6/30/2019 EPS -0.030 ZacksConsensus -0.230 ActVsEst 0.200 - Beat 7.0%
5/13 Tandem Diabetes Care Announces Upcoming Conference Presentations 6.8%
2/10 Form SC 13G/A TANDEM DIABETES CARE Filed by: WELLINGTON MANAGEMENT GROUP LLP 6.8%
4/29 Tandem Diabetes Care Q1 2020 Earnings Preview [Seeking Alpha] 5.8%
11/18 Form 4 TANDEM DIABETES CARE For: Nov 18 Filed by: Vosseller Leigh 5.8%
3/2 Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller 5.7%
TOP News Decliners
3/14
Tandem Diabetes Care Inc (NASDAQ: TNDM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating.
-15.8%
2/24 Q4/2019 12/31/2019 EPS 0.040 ZacksConsensus -0.080 ActVsEst 0.120 - Beat -11.9%
11/4 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.200 ActVsEst 0.110 - Beat -7.6%
6/7 Tandem Diabetes Care Announces Conference Call Following Data Presentations at the ADA Scientific Sessions -6.4%
8/14 Form 4 TANDEM DIABETES CARE For: Aug 13 Filed by: CAHILL EDWARD L -6.1%
10/1 2 Growth Stocks for In-the-Know Investors [The Motley Fool] -5.9%
8/13 Form 4 TANDEM DIABETES CARE For: Aug 12 Filed by: HANSEN BRIAN B -5.4%
8/6 Form 4 TANDEM DIABETES CARE For: Aug 02 Filed by: ROEDER DOUGLAS A -4.7%
8/30 Form 4 TANDEM DIABETES CARE For: Aug 28 Filed by: BLICKENSTAFF KIM D -4.6%
1/30 Tandem Diabetes Care Inc (NASDAQ: TNDM) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.6%
2/24 Q4/2019 12/31/2019 EPS 0.040 ZacksConsensus -0.080 ActVsEst 0.120 - Beat -11.9%
11/4 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.200 ActVsEst 0.110 - Beat -7.6%
6/7 Tandem Diabetes Care Announces Conference Call Following Data Presentations at the ADA Scientific Sessions -6.4%
8/14 Form 4 TANDEM DIABETES CARE For: Aug 13 Filed by: CAHILL EDWARD L -6.1%
10/1 2 Growth Stocks for In-the-Know Investors [The Motley Fool] -5.9%
8/13 Form 4 TANDEM DIABETES CARE For: Aug 12 Filed by: HANSEN BRIAN B -5.4%
8/6 Form 4 TANDEM DIABETES CARE For: Aug 02 Filed by: ROEDER DOUGLAS A -4.7%
8/30 Form 4 TANDEM DIABETES CARE For: Aug 28 Filed by: BLICKENSTAFF KIM D -4.6%
1/30 Tandem Diabetes Care Inc (NASDAQ: TNDM) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: